Drugs / Netivudine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00002315 | — | HIV infectious disease, chickenpox | Glaxo Wellcome | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Netivudine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00002315 ↗ |
| Known as | 882C-87 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1097615 ↗ |
| Known as | Netivudina | ChEMBL registry synonym — accepted as the source's own label CHEMBL1097615 ↗ |
| Modality | Small molecule | — CHEMBL1097615 ↗ |